An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer

Cell. 2008 Nov 28;135(5):852-64. doi: 10.1016/j.cell.2008.09.061. Epub 2008 Nov 13.

Abstract

Cancers are highly heterogeneous and contain many passenger and driver mutations. To functionally identify tumor suppressor genes relevant to human cancer, we compiled pools of short hairpin RNAs (shRNAs) targeting the mouse orthologs of genes recurrently deleted in a series of human hepatocellular carcinomas and tested their ability to promote tumorigenesis in a mosaic mouse model. In contrast to randomly selected shRNA pools, many deletion-specific pools accelerated hepatocarcinogenesis in mice. Through further analysis, we identified and validated 13 tumor suppressor genes, 12 of which had not been linked to cancer before. One gene, XPO4, encodes a nuclear export protein whose substrate, EIF5A2, is amplified in human tumors, is required for proliferation of XPO4-deficient tumor cells, and promotes hepatocellular carcinoma in mice. Our results establish the feasibility of in vivo RNAi screens and illustrate how combining cancer genomics, RNA interference, and mosaic mouse models can facilitate the functional annotation of the cancer genome.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / genetics*
  • Genes, Tumor Suppressor*
  • Genomics*
  • Humans
  • Karyopherins / genetics
  • Karyopherins / metabolism
  • Liver Neoplasms / genetics*
  • Mice
  • Peptide Initiation Factors / genetics
  • RNA Interference*
  • RNA, Untranslated / genetics
  • RNA-Binding Proteins / genetics
  • Smad3 Protein / metabolism

Substances

  • Karyopherins
  • Peptide Initiation Factors
  • RNA, Untranslated
  • RNA-Binding Proteins
  • SMAD3 protein, human
  • Smad3 Protein
  • Xpo4 protein, human
  • eukaryotic translation initiation factor 5A